IPXL Financial Facts
Patent litigation: 3.28MInterest expense: -11.09M
See Full Income Statement
Accrued profit sharing and royalty expenses: 19.76M
Retained earnings: 377.78M
See Full Balance Sheet
Impax Laboratories Inc. (IPXL) Earnings
|
Expand Research on IPXL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/14  |
 |
Q413 | -$0.14 | $0.03 | -$0.17 | $100.74M | $119.01M | N/A |  | | Details |
| 11/4/13 |
|
Q313 | $0.00 | -$0.07 | +$0.07 | $132.6M | $111.83M | N/A | | | Details |
| 8/8/13 |
|
Q213 | $0.08 | $0.04 | +$0.04 | $129.63M | $120.75M | N/A | | | Details |
| 5/11/15 |
|
Q115 | $0.09 | $0.18 | -$0.09 | $143.1M | $146M | N/A | | | Details |
| 3/1/18 | |
Q417 | $0.11 | $0.11 | $0.00 | $182.9M | $198.17M | = | | | Details |
| 5/10/17 | |
Q117 | $0.11 | $0.13 | -$0.02 | $184.4M | $191.25M | = | | | Details |
| 2/24/15 |
|
Q414 | $0.16 | $0.12 | +$0.04 | $131.2M | $125.5M | N/A | | | Details |
| 3/1/17 | |
Q416 | $0.16 | $0.16 | $0.00 | $198.4M | $219.25M | = | | | Details |
